baber/WOPTO huggingface dataset:
Patent NZ-513245-A (NZ)
Title: Method to detect male antifertility problems
Inventor: FLOHE LEOPOLD
IPC: C12Q1/28
Filed: 2000-03-06
Abstract: Method to detect male anti-fertility problems based on the determination of latent phospholipid hydroperoxide glutathione peroxidase (PHGPx) comprising the steps of: (a) Obtaining a sperm sample; (b) Solubilising the spermatozoa by using detergents and chaotropic agents and reactivating latent PHGPx by using high concentrations of thiols, wherein the thiol concentration is sufficient to fully dissolve the sperm mitochondrial capsule; and (c) Determining enzymatic activity of reactivated latent PHGPx.
Patent NZ-514558-A (NZ)
Title: Viral treatment
Inventor: CAMDEN JAMES BERGER
IPC: A61K9/107
Filed: 2000-03-29
Abstract: The use of a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a 2-thienyl imidazolo [4,5]pyridine derivative of the general formula shown below for making a medicament for treating a viral infection or a Cryptococcus or Curvularia fungal infection.
Patent NZ-521746-A (NZ)
Title: Kill-trap for possum control with upper and lower jaws from extensions of two coil springs, with latching device
Inventor: THOMAS MALCOLM DAVID
IPC: A01M23/24
Filed: 2002-10-03
Abstract: Two  coil springs are extended to form upper  (1)  and lower jaws.  In use, an animal, typically a possum pulls  on bait  (4)  to lift trigger plate (3) which releases  trigger bar  (2)  which  in  turn releases upper jaw  1  which  then closes.
Patent NZ-522955-A (NZ)
Title: Method and installation for drying sludge
Inventor: STUMMER GISELHER
IPC: F26B1/00
Filed: 2001-06-07
Abstract: The invention relates to a method for drying sludge, in particular sewage sludge, by creating a granulate from the dried product. According to said method, a mixture of a carrier material consisting of recycled sludge which has already been dried and liquid sludge is fed to a dryer (6). The invention is characterised in that the dried product is fed to a sediment separator (8) after the dryer (6) and is stored intermediately in the former in an intermediate container that is placed immediately downstream of said separator. The invention also relates to an installation for carrying out said method.
Patent NZ-526100-A (NZ)
Title: Fumaric acid amides
Inventor: JOSHI RAJENDRA KUMAR
IPC: A61P31/04
Filed: 2002-01-08
Abstract: Disclosed are fumaric acid amide compounds of formula (I), wherein: R1 is OR3 or a D- or L-amino acid radical -NH-CHR4-COOH bonded via an amide bond, wherein R3 is H, optionally substituted alkyl, phenyl or aralkyl and R4 is a side chain of a natural or synthetic amino acid, and R2 is a D- or L-amino radical -NH-CHR5-COOH bonded via an amide bond, wherein R5 is a side chain of a natural or synthetic amino acid. The compounds are used in the manufacture of medicaments for the therapy of autoimmune diseases, for use in transplantation medicine, for therapy of mitochondrial diseases and for therapy of NF-kappaB mediated diseases.
Patent NZ-526755-A (NZ)
Title: Multi-tiered comps promotion with accumulated comps and delivery by mail
Inventor: NORTON DAVID
IPC: A63F5/04
Filed: 2003-06-30
Abstract: Whether a patron of a gaming enterprise qualifies as a "high value" patron is determined in accordance with the patron's average expected activity during a particular time period. "Comps" are awarded to the patron based on the patron's average expected activity if a patron is determined to be a high value patron, or based on the patron's accumulated expected activity otherwise. The method is implemented by computer.
Patent NZ-528383-A (NZ)
Title: Flushing device for a lavatory
Inventor: GUBELI ALBERT
IPC: E03D1/22
Filed: 2002-03-21
Abstract: Disclosed is a flushing device for a lavatory, having a flushing cistern (1) in which is arranged at least one pressure vessel (8, 9) which has a feed line for water and a discharge valve and in which at least some of the flushing water can be subjected to pressure and can be discharged trough the discharge valve for flushing purposes, wherein at least one pressure-cylinder unit in which flushing water can be subjected to pressure and can be discharged by way of a spring- force-loaded pressure piston for flushing purposes, characterized in that the pressure piston is locked in a starting position and can be unlocked for flushing purposes.
Patent NZ-529085-A (NZ)
Title: Compositions and therapeutic methods involving isoflavones and analogues thereof
Inventor: HEATON ANDREW
IPC: A23L1/30
Filed: 2000-09-06
Abstract: Disclosed are isoflavone compounds, of which exemplified and preferred compounds are shown. The compounds are used in the manufacture of medicaments for the treatment of diseases mediated by the estrogen receptor.
Patent NZ-532529-A (NZ)
Title: Package lid, method for manufacturing the same and package sealed with the lid
Inventor: PENTTINEN TAPANI
IPC: B65D53/00
Filed: 2002-10-15
Abstract: Here is disclosed a lid (1) that can be heat-sealed to an opening of a package (2) and peeled off as the package is opened, comprising a fibrous material layer, a polymer oxygen-barrier layer and a polymer heat-seal layer, characterized in that the heat-seal layer comprises ethylene methyl acrylate copolymer (EMA) ethylene vinyl acetate copolymer (EVA) and polyamide wax, and in that the heat-seal layer is adhered directly to the oxygen-barrier layer having a higher melting point without any intermediate binder.
Patent NZ-535489-A (NZ)
Title: Stream straightener for fluid dispensing nozzle
Inventor: MITCHELL THOMAS O
IPC: B67D7/54
Filed: 2003-02-26
Abstract: A choke for reducing spray of fuel exiting a fuel dispensing system nozzle spout (S) is disclosed. The choke has an annular frame positioned within the spout (S) adjacent the output opening (O). A concentric hub is connected to the frame by three relatively narrow struts positioned equidistant around the hub. The hub has a solid, cylindrical fore section and a tubular aft section. A duct extends from the tubular aft section, through one strut and the frame, to the venturi opening (V). Fuel flowing through the spout (S) toward the output opening (O) is slowed and divided into three streams by the choke, it then flows along the hub fore section and converges, compressed and linearly aligned, at the output opening (O) of the spout (S) to reduce spraying of fuel at the output opening (O) of the spout (S).
Patent NZ-536693-A (NZ)
Title: Controlled release dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
Inventor: FINK TRACY ANN
IPC: A61K9/22
Filed: 2003-05-28
Abstract: Disclosed is a controlled release oral dosage form for once-a-day administration of oxycodone comprising: (a) a drug core which comprises: (i) an osmotic agent; and (ii) a low dose of oxycodone, or one or more pharmaceutically-acceptable salts thereof; (b) a semipermeable membrane at least partially surrounding the drug core; (c) an exit orifice through the semipermeable membrane which communicates with the drug core so as to allow release of the oxycodone to the environment; and (d) an expandable layer which does not comprise oxycodone; wherein the drug core upon hydration in the environment exhibits a viscosity of about 50 cps to 100 cps.
Patent NZ-537330-A (NZ)
Title: Piperidine derivative, process for producing the same, and use
Inventor: IKEURA YOSHINORI
IPC: C07D401/10
Filed: 2003-05-29
Abstract: Disclosed are piperidine derivatives of formula (I) and methods of preparing them wherein: Ar is an optionally substituted phenyl group, a benzhydryl group or a benzyl group; R1 is H, an optionally substituted hydrocarbon group or an acyl group as defined; X is O or NH; Z is a methylene group; ring A is an optionally further substituted piperidine ring; and ring B is an optionally substituted benzene ring. Compounds of the type disclosed are useful as tachykinin receptor antagonists for the prevention or treatment of abnormality of lower urinary tract functions, digestive organ diseases, inflammatory or allergic diseases, arthropathy and/or osteopathy, respiratory diseases, infection, cancer, central nerve diseases, circulatory diseases, pain, autoimmune diseases, hepatic diseases, pancreatic diseases, renal diseases, metabolic diseases, endocrine diseases, graft rejections, abnormality in characteristic of blood and/or blood components, gynaecologic diseases, dermatic diseases, ophthalmic disease, otolaryngological diseases, disease due to environment and/or occupational factors, ataxia or chronic fatigue syndrome.
Patent NZ-538660-A (NZ)
Title: Rate adaptive transmission scheme for MIMO systems
Inventor: AGRAWAL AVNEESH
IPC: H04L1/06
Filed: 2003-10-14
Abstract: A rate adaptive transmission scheme for MIMO systems, which can transmit a variable number of data symbol streams, provide transmit diversity for each data symbol stream, and fully utilize the total transmit power of the system and the full power of each antenna is disclosed. In one method at least one data symbol stream is received for transmission from a plurality of antennas. Each data symbol stream is scaled with a respective weight corresponding to the amount of transmit power allocated to that stream. The scaled data symbol stream(s) are multiplied with a transmit basis matrix to provide a plurality of transmit symbol streams for the plurality of antennas. The transmit basis matrix (e.g., a Walsh-Hadamard matrix or a DFT matrix) is defined such that each data symbol stream is transmitted from all antennas and each transmit symbol stream is transmitted at (or near) the full power for the associated antenna.
Patent NZ-542464-A (NZ)
Title: Ink cartridge and recording apparatus
Inventor: HASHII KAZUHIRO
IPC: B41J/
Filed: 2003-08-29
Abstract: Disclosed in an ink cartridge including an ink supply port formed at a position, offset to one side, of a wall configuring an ink container body, a positioning projection portion, formed on one wall out of two opposing walls adjacent the wall, whose upper surface and side portion are regulated in position when the cartridge has been mounted on a recording apparatus, a lever, formed on the other wall out of the two walls, maintaining a normal hinged-open state and having a projection that is forcibly displaced outward when the cartridge is mounted on the recording apparatus, and electrodes that are connected to a memory unit formed on the positioning projecting portion.
Patent NZ-543085-A (NZ)
Title: Method and apparatus for sterilization and vacuum packing in a hospital, laboratory or food processing environment
Inventor: KEMP TERRY DEAN
Filed: 2005-10-20
Abstract: A method for sterilization and vacuum packing, in environments such as a hospital, a laboratory or a food processing plant, involves placing the item(s) to be sterilized into an impenetrable sealable packaging. A sterilization process is then carried out solely within the packaging by applying a vacuum to the interior of the sealable packaging and introducing sterilant. The sealable packaging is then sealed at the completion of the sterilization process.
Patent NZ-543582-A (NZ)
Title: Extraction process for a pharmaceutical product
Inventor: MANICKAVASAGAM BHANU
IPC: C07K1/14
Filed: 2004-04-30
Abstract: Disclosed is a process for isolating a soluble, native collagen from a marine invertebrate, comprising the steps: 1) treating a collagen-containing portion of the marine invertebrate with a weak acid solution in order to solubilise native collagen fibrils; 2) centrifuging the resultant slurry to remove tissue particulates; 3) adjusting the pH of the supernatant in order to precipitate collagen by addition of a base; 4) collecting the precipitated collagen; 5) resuspending the precipitated collagen; and 6) performing buffer exchange against water using an ultrafiltration membrane. Has Patent of Addition No. 544672
Patent NZ-544664-A (NZ)
Title: Fluidising mat, container and container liner with such a mat
Inventor: BROWN DAVID MICHAEL
IPC: B65D88/72
Filed: 2004-07-16
Abstract: A fluidising mat for use within a bulk materials container includes an upper gas permeable sheet 2 and a lower gas impermeable sheet 3 spaced apart by a plurality of spaced apart load bearing elements 4 which define a plurality of passageways that extend in different directions over the full area of the mat and intersect each other to form a single continuous chamber between the upper and lower sheets. The sheets and the load bearing elements are flexible or resiliently deformable so that the mat can be folded or rolled up.
Patent NZ-545036-A (NZ)
Title: Breathing assistance device with axial flow modular ventilator
Inventor: CHALVIGNAC PHILIPPE
IPC: A61M16/06
Filed: 2004-07-05
Abstract: A breathing assistance device for a patient P includes a ventilator in the form of a removable module 20 that is directly connected to the ventilator mask 420 which does not have leakage. The ventilator is preferably an axial fan ventilator including pressure and flow sensors for the gas, air, supplied to the mask via the fan.
Patent NZ-550541-A (NZ)
Title: Compositions and methods for the modification of gene transcription comprising sequences 377, 396 and 2046
Inventor: WOOD MARION
Filed: 2000-03-09
Abstract: Disclosed is an isolated polynucleotide comprising a sequence selected from the group consisting of sequences provided in SEQ ID NO 377, 396 and 2046. Also disclosed is a DNA construct comprising the polynucleotide. Also disclosed is a plant cell, or wood obtained from a transgenic tree, or wood pulp obtained from a transgenic tree, or fruit, seeds or other reproductive material from a transgenic plant, which has been transformed with the above DNA construct.
Patent NZ-553172-A (NZ)
Title: Isoxazoline derivatives and their use as herbicides
Inventor: PLANT ANDREW
Filed: 2005-08-17
Abstract: Disclosed is a compound of formula (I), with substituents as described in the specification, and a process for its preparation. Also disclosed is the use of the compound for controlling grasses and weed in crops of useful plants.
Patent NZ-573308-A (NZ)
Title: Adenosine derivatives for the treatment of pain
Inventor: SAVORY EDWARD DANIEL
IPC: C07H19/16
Filed: 2007-06-26
Abstract: A compound of the following general formula (I) e.g. (2R,3R,5S)-2-[6-amino-2-(cyclopentylamino)-9H-purin-9-yl]-S-(hydroxymethyl)tetrahydrofuran-3-ol wherein when X=Y=Z=OH, R1 is OCH2CF2CF3, phenoxy (substituted with 3-(4-trifluoromethylphenyl), 3,4-dichloro, (3-trifluoromethyl,4-fluoro), (3-trifluoromethyl,4-chloro), (3-chloro, 4-cyano), or 3,5-bis(trifluoromethyl)), 1-piperazinyl( 4-(3,4-dichlorophenyl)), phenyl (substituted with 3,4-dichloro, 3,5-difluoro, 3,5-bis(trifluoromethyl) or 3,4,5-trifluoro) or 2-benzofuranyl or a pharmaceutically acceptable salt thereof for the treatment of pain and inflammation.
Patent NZ-575166-A (NZ)
Title: A method of improving membrane bioreactor performance
Inventor: YOON SEONG-HOON
IPC: C02F1/28
Filed: 2007-09-05
Abstract: Disclosed is a method of conditioning an activated sludge in a MBR that treats industrial wastewater comprising at least the step of adding to said activated sludge an effective amount of one or more cationic polymers, wherein said cationic polymers have a molecular weight of about 200,000 daltons or greater, and wherein said polymers are added to said activated sludge by adding said cationic polymers to an anoxic tank of said MBR and wherein said cationic polymers have a net cationic charge that ranges from about 5% to about 100% based on the number of monomers in said cationic polymers.
Patent NZ-580622-A (NZ)
Title: Imidazoquinolines with immuno-modulating properties
Inventor: BONNERT ROGER VICTOR
IPC: A61P37/02
Filed: 2008-05-06
Abstract: Disclosed are imidazoquinolines represented by general formula (I), such as methyl 2-(4-((3-(4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)propylamino)methyl)phenyl)acetate, or pharmaceutically acceptable salts thereof. Also discloses is the use of the compounds of formula (I) for treating allergic or viral diseases or cancers or for use in treating asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dennatitis, cancer, hepatitis B, hepatitis C, HIV, HPV, bacterial infections and dennatosis, as well as diseases in which modulation of TLR7 activity is beneficial.
Patent NZ-580903-A (NZ)
Title: Plant treatment material
Inventor: TOYE JONATHAN DALLAS
IPC: A01G13/00
Filed: 2005-07-22
Abstract: A plastic, reflective ground cover sheet material woven from warp tapes and weft tapes in which the longitudinally extending opposite side margins 52 of the ground cover sheet material have been woven with a tighter or denser weave and with a lower percentage of the surface area made up of apertures through the material than that of the longitudinally extending centre section 53 that lies between the longitudinally extending side margins 52. (62) Divided Out of 570110
Patent NZ-586319-A (NZ)
Title: Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent
Inventor: NOUJAIM ANTOINE
IPC: A61K31/765
Filed: 2008-11-26
Abstract: Disclosed are methods and compositions for targeting and delivering solid-phase platelet dependent vascular occlusion agents. In particular, particles or coils or stents coated with platelet binding agents are directed to target vasculature, such as the vasculature of solid tumor masses or AV-malformations or aneurysms or endoleaks; the solid-phase agent then binds and activates platelets, which in turn bind and activate other platelets. This process results in the rapid formation of a platelet-mediated thrombus about the solid-phase agent causing vessel occlusion. The agent comprises poly(lactic-coglycolic acid) microspheres coated with bovine fibrillar collagen type 1, and wherein the connective tissue replaces the biodegradable solid-phase agent as the biodegradable solid-phase agent degrades.
Patent NZ-588252-A (NZ)
Title: Process for the preparation of donepezil hydrochloride
Inventor: RAO DHARMARAJ RAMACHANDRA
IPC: A61K31/445
Filed: 2009-03-24
Abstract: Disclosed is a process for preparing donepezil ((RS)-2-[(1-benzyl-4-piperidyl)methyl]- 5,6-dimethoxy-2,3-dihydroinden-1-one) or a salt thereof, the process comprising reducing a 1-benzyl-4-[( 5,6-dimethoxy-1-indanon-2-yl)methylene]pyridonium halide of formula II wherein X- is chloride or bromide, in the presence of an ionic compound, a solvent, a catalyst and a source of hydrogen, to form donepezil and optionally converting donepezil to the salt thereof. Also disclosed is donepezil prepared by the process, a pharmaceutical formulation comprising donepezil prepared by the process and the use of donepezil prepared by the process in the manufacture of a medicament for the treatment of a diseases treated by a cholinesterase inhibitor such as Alzheimer's disease.
Patent NZ-589380-A (NZ)
Title: Data Entry System and method for predicitve data entry
Inventor: GHASSABIAN FIROOZ
IPC: G06F3/023
Filed: 2006-06-16
Abstract: A data entry system and a method of word predictive data entry of a desired word are disclosed. The data entry system comprises (a) first input means to provide input signals ambiguously corresponding to a plurality of characters; (b) second input means, different from the first input means, to provide correction information; (c) a dictionary database of words and (d) a word predictive system to predict a first word from the dictionary of words based on the input signals and if the second input means receives correction information the word predictive system provides a second word based on the input signals and the correction information, and the second input means is used to provide correction information to precisely define at least the beginning character of the desired word.
Patent NZ-595270-A (NZ)
Title: Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
Inventor: HARADA YASUHIRO
IPC: A61K9/48
Filed: 2008-07-16
Abstract: Disclosed is a soft gelatin capsule formulation comprising: an 11-deoxy-prostaglandin compound represent by general formula (II), a soft gelatin capsule shell comprising a polyol which is not a sugar alcohol, and a fatty acid ester obtained from a fatty acid having C6-24 carbon atoms, such as capric, lauric or oleic acid, and an alcohol selected from the group consisting of C1-6 monovalent alcohol, glycerine and propylene glycol.
Patent NZ-600536-A (NZ)
Title: Bicyclic compounds as alpha4 beta2 nicotinic acetylcholine receptor ligands
Inventor: NIROGI RAMAKRISHNA
IPC: A61K31/403
Filed: 2009-12-31
Abstract: 600536 The present disclosure relates to novel bicyclic compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present disclosure also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment and prevention of various disorders that are related to ?4?2 nicotinic receptors.
Patent NZ-605535-A (NZ)
Title: Fipronil production process
Inventor: LEVIN ANAT
IPC: C07D231/44
Filed: 2011-07-10
Abstract: Disclosed herein is an oxidation process for preparing 5-amino-3-cyano-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-trifluoromethylsulphinyl-pyrazole, of formula (I). The process includes admixing 5-amino-3-cyano-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-trifluoro-methylthiopyrazole of formula (II) with dichloroacetic acid and hydrogen peroxide in the presence of a strong acid such as sulfuric acid, methanesulfonic acid and p-toluenesulfonic acid.
Patent NZ-610706-A (NZ)
Title: Method for injecting electrons into a fusion-fuel derived plasma
Inventor: BIRNBACH CURTIS A
IPC: G21B1/19
Filed: 2009-08-28
Abstract: Disclosed is a method for injecting electrons of predetermined energy and quantity into an inertial confinement fusion fuel-derived plasma to enhance the pre-ignition conditions of thermonuclear fusion reactions using a plurality of electron or x-ray sources to control the ratio of ion and electron temperatures of the plasma. The method comprises providing a central target chamber for receiving a spherical pellet of fusion fuel; and providing a plurality of energy drivers arranged in symmetrical pairs about the fusion fuel pellet, and oriented to direct a first energy pulse of optical laser light, X-ray pulses or ions into the fusion fuel in a 3-dimensionally symmetric manner about the fusion fuel pellet and providing a plurality of electron sources, each of which creates an electron beam of a predetermined energy and quantity. The plurality of energy drivers are operated for illuminating and ionizing the spherical pellet to create a fusion fuel-derived plasma; and then the plurality of energy drivers are operated to cause the electron beams to permeate the fusion fuel-derived plasma. The energy level of the electron beams are adjusted via a controlled input. The current of the electron beams are adjusted via a controlled input. The electron sources focus the electron beams into the fusion fuel-derived plasma. The plurality of electron sources are controlled so that they inject a pulse of electrons of predetermined energy, pulse width, and quantity into the fusion fuel-derived plasma as a predetermined interval of picosecond or finer increments after said first energy pulse. An RF pulse is injected with a predetermined delay from the first energy pulse, into the fusion fuel-derived plasma.